Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -7.44%31.62B | -8.66%21.24B | -5.47%12.54B | -10.24%48.71B | -9.00%34.16B | 6.61%23.25B | 31.48%13.27B | 18.18%54.26B | 19.32%37.54B | 8.20%21.81B |
| Refunds of taxes and levies | 5.02%141.13M | 88.75%120.8M | 144.97%63.71M | -18.19%148.2M | -10.32%134.39M | -51.75%64M | -38.26%26.01M | -7.21%181.15M | -14.32%149.86M | 33.60%132.63M |
| Net deposit increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | -39.89%1.12B | -49.47%571.15M | -54.81%352.17M | -15.13%1.83B | 20.35%1.86B | 36.76%1.13B | 5.94%779.38M | 11.49%2.15B | -14.06%1.54B | -11.30%826.47M |
| Cash inflows from operating activities | -9.06%32.87B | -10.29%21.93B | -7.93%12.96B | -10.45%50.69B | -7.85%36.15B | 7.36%24.45B | 29.48%14.07B | 17.80%56.6B | 17.35%39.23B | 7.46%22.77B |
| Goods services cash paid | 0.13%31.05B | 1.71%21.93B | 0.17%12.33B | -12.61%39.97B | -1.39%31.01B | 7.59%21.56B | 24.46%12.31B | 15.60%45.74B | 11.23%31.44B | 8.61%20.04B |
| Staff behalf paid | -16.37%4.14B | -12.32%3.12B | -29.17%1.7B | 0.12%6.38B | 2.98%4.96B | -0.74%3.56B | 27.16%2.39B | 9.51%6.37B | 18.98%4.81B | 21.60%3.59B |
| All taxes paid | -13.13%844.81M | -17.49%607.95M | -11.55%303.73M | -7.10%1.35B | 0.43%972.46M | 3.84%736.82M | -2.96%343.37M | 26.05%1.45B | -1.66%968.32M | -2.00%709.56M |
| Net loan and advance increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net lend capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -4.24%1.51B | -49.06%726.63M | -42.56%539.46M | -9.11%2.17B | -19.01%1.58B | 26.32%1.43B | -2.26%939.13M | 35.50%2.39B | 4.55%1.95B | 17.29%1.13B |
| Cash outflows from operating activities | -2.50%37.55B | -3.29%26.39B | -6.99%14.87B | -10.87%49.87B | -1.69%38.51B | 7.15%27.29B | 22.14%15.99B | 15.84%55.94B | 11.40%39.17B | 10.30%25.47B |
| Net cash flows from operating activities | -97.69%-4.67B | -56.91%-4.46B | 0.06%-1.91B | 25.25%820.79M | -4,281.49%-2.36B | -5.33%-2.84B | 13.80%-1.91B | 365.46%655.31M | 103.26%56.51M | -41.95%-2.7B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -99.20%1.78M | ---- | --0 | -18.00%230.85M | 24.12%222.32M | --122.97M | --0 | 768.22%281.51M | 905.02%179.11M | ---- |
| Cash received from returns on investments | -30.41%24.21M | 10.07%2M | --2M | 492.22%42.5M | 732.20%34.79M | 35.21%1.81M | --0 | 281.69%7.18M | 124.97%4.18M | -29.38%1.34M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -31.89%64.5M | 2,197.87%64.2M | 11,749.88%50.8M | 1,697.29%98.03M | 21,566.44%94.7M | 654.49%2.79M | 636.81%428.71K | 607.42%5.45M | -25.89%437.09K | -15.24%370.29K |
| Net cash received from disposal of subsidiaries and other business units | 162.22%128.42M | --382.45 | --0 | --48.97M | --48.97M | ---- | --0 | ---- | --0 | ---- |
| Cash received relating to other investing activities | -87.39%15.3M | -99.48%604.5K | 555.19%221.13K | -10.61%160.81M | 731.05%121.29M | --115.23M | --33.75K | 492.52%179.9M | -51.93%14.6M | ---- |
| Cash inflows from investing activities | -55.14%234.22M | -72.49%66.8M | 11,364.53%53.02M | 22.60%581.16M | 163.25%522.09M | 14,086.91%242.81M | 694.82%462.46K | 624.40%474.04M | 291.70%198.33M | -94.77%1.71M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -20.72%223.45M | 11.28%187.44M | 7.94%128.61M | -18.41%534.73M | -36.32%281.86M | -33.90%168.44M | -30.26%119.15M | 2.28%655.38M | 0.31%442.66M | -14.03%254.85M |
| Cash paid to acquire investments | -81.38%6.69M | -84.85%6.66M | 541.31%6.28M | -47.97%34.05M | 51.64%35.93M | 230.49%43.98M | 230.00%980K | -83.13%65.45M | -93.89%23.7M | -95.14%13.31M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | --26.26M | ---- | ---- | --0 | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | -85.18%3.87M | -96.10%901.57K | --0 | -84.25%28.2M | 56.56%26.14M | --23.14M | --0 | 151.86%179M | 178.21%16.7M | ---- |
| Cash outflows from investing activities | -31.96%234.01M | -17.22%195M | 12.29%134.89M | -30.74%623.25M | -28.80%343.94M | -12.15%235.57M | -29.81%120.13M | -40.82%899.82M | -44.50%483.05M | -53.47%268.15M |
| Net cash flows from investing activities | -99.89%204.04K | -1,871.12%-128.2M | 31.58%-81.87M | 90.12%-42.09M | 162.57%178.14M | 102.72%7.24M | 30.06%-119.66M | 70.74%-425.78M | 65.27%-284.72M | 50.99%-266.44M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --0 | --0 | -69.32%341.06M | -84.89%167.06M | -89.24%118.06M | -95.50%48M | 244.22%1.11B | 4,197.74%1.11B | 4,429.07%1.1B |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --0 | --0 | -69.32%341.06M | -84.89%167.06M | -89.24%118.06M | -95.50%48M | 244.22%1.11B | 4,197.74%1.11B | 4,429.07%1.1B |
| Cash from borrowing | -11.39%6.33B | -14.85%3.62B | -2.73%2.35B | 51.29%8.81B | 43.28%7.14B | 12.57%4.25B | 9.41%2.41B | -30.78%5.82B | -30.87%4.98B | -19.46%3.77B |
| Cash received relating to other financing activities | -95.07%1.65M | --1.65M | --1.65M | --429.47M | --33.56M | --0 | --0 | ---- | --0 | ---- |
| Cash inflows from financing activities | -13.78%6.33B | -17.11%3.62B | -4.56%2.35B | 38.15%9.58B | 20.56%7.34B | -10.37%4.36B | -24.78%2.46B | -21.49%6.93B | -15.92%6.09B | 3.43%4.87B |
| Borrowing repayment | -9.09%4.57B | 59.42%2.66B | 251.94%1.82B | 24.25%7.19B | 16.48%5.03B | -9.11%1.67B | -43.89%517.7M | -3.92%5.78B | -1.45%4.32B | 25.38%1.83B |
| Dividend interest payment | 55.83%715.62M | 65.80%552.75M | 92.12%174.28M | -29.73%579.78M | -18.08%459.22M | 2.30%333.38M | -18.31%90.71M | 21.16%825.12M | -2.20%560.54M | -16.98%325.89M |
| -Including:Cash payments for dividends or profit to minority shareholders | 893.59%297.09M | 2,335.92%239.88M | --0 | -85.97%42.51M | 41.09%29.9M | 70.97%9.85M | --0 | 71.76%302.97M | -87.50%21.19M | -93.91%5.76M |
| Cash payments relating to other financing activities | 198.22%280.89M | 536.86%256.15M | 195.66%58.15M | 97.20%262.95M | 0.75%94.19M | -36.12%40.22M | 10.93%19.67M | 143.92%133.34M | 179.84%93.48M | 257.28%62.97M |
| Cash outflows from financing activities | -0.25%5.57B | 69.87%3.47B | 227.10%2.05B | 19.09%8.03B | 12.29%5.58B | -8.20%2.04B | -40.27%628.08M | -0.19%6.74B | -0.32%4.97B | 18.68%2.22B |
| Net cash flows from financing activities | -56.82%758.38M | -93.50%151.01M | -83.86%296.12M | 711.05%1.55B | 57.43%1.76B | -12.20%2.32B | -17.45%1.83B | -90.80%190.95M | -50.48%1.12B | -6.65%2.65B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -35.36%1.69M | 284.60%4.31M | 85.33%-408.41K | 64.85%5.18M | 461.30%2.61M | -1,070.39%-2.33M | 38.87%-2.78M | -77.05%3.14M | -105.63%-722.77K | -91.37%240.49K |
| Net increase in cash and cash equivalents | -817.77%-3.91B | -763.45%-4.43B | -749.47%-1.7B | 450.63%2.33B | -148.07%-426.2M | -61.45%-513.2M | -16.57%-199.79M | 9.47%423.62M | 406.38%886.62M | -180.87%-317.88M |
| Add:Begin period cash and cash equivalents | 29.28%10.3B | 29.28%10.3B | 29.28%10.3B | 5.62%7.97B | 5.62%7.97B | 5.62%7.97B | 5.62%7.97B | 5.41%7.54B | 5.41%7.54B | 5.41%7.54B |
| End period cash equivalent | -15.29%6.39B | -21.27%5.87B | 10.75%8.6B | 29.28%10.3B | -10.55%7.54B | 3.16%7.45B | 5.36%7.77B | 5.62%7.97B | 22.76%8.43B | -4.29%7.22B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.